Alefacept is indicated for:
Population group: both men and women, only adults (18 years old or older)
Alefacept is indicated is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Alefacept is contraindicated in the following cases: